Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | MSH6 |
Variant | E946* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | MSH6 E946* results in a premature truncation of the Msh6 protein at amino acid 946 of 1360 (UniProt.org). E946* has not been characterized, however, due to the loss of several functional domains including the ATPase domain (PMID: 17531815, PMID: 23391514), is predicted to lead to a loss of Msh6 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
MSH6 mutant MSH6 inact mut MSH6 E946* |
Transcript | NM_000179.3 |
gDNA | chr2:g.47800819G>T |
cDNA | c.2836G>T |
Protein | p.E946* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001406796.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406808.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406803.1 | chr2:g.47806257G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
XM_024452819.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406799.1 | chr2:g.47803608G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406800.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_000179.3 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406809.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406807.1 | chr2:g.47803608G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406798.1 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_000179 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_001406806.1 | chr2:g.47803608G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
NM_000179.2 | chr2:g.47800819G>T | c.2836G>T | p.E946* | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|